---
title: "Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform  | TRIB Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278549850.md"
description: "Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform | TRIB Stock News"
datetime: "2026-03-10T03:55:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278549850.md)
  - [en](https://longbridge.com/en/news/278549850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278549850.md)
---

# Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform  | TRIB Stock News

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform | TRIB Stock News

### Related Stocks

- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [TRIB.US](https://longbridge.com/en/quote/TRIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)